IP Library Granted Patent US 8,076,455
Granted Patent B2
US 8,076,455 · App. 12/716,906 · Granted Dec 13, 2011

Guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,076,455
App. No.
12/716,906
Granted
Dec 13, 2011
Kind
B2
Abstract

The present inventors conducted a similarity search of the amino acid sequence of known G protein-coupled receptor proteins in GenBank, and obtained a novel human GPCR gene “BG37”, cDNA containing the ORF of the gene was cloned and its nucleotide sequence was determined. Moreover, novel GPCR “BG37” genes from mouse and rat were isolated. Use of the novel GPCR of the present invention enables screening of ligands, compounds inhibiting the binding to a ligand, and candidate compounds of pharmaceuticals which can regulate signal transduction from the “BG37” receptor.

Claims (6)

1. An isolated protein selected from the group consisting of:

(a) a protein comprising the amino acid sequence of SEQ ID NO: 2;

(b) a protein comprising the amino acid sequence of SEQ ID NO: 2 with one to three amino acid substitutions, deletions, additions and/or insertions, wherein said protein is a guanosine triphosphate-binding protein-coupled receptor protein;

(c) a protein encoded by a DNA comprising the coding region of the nucleotide sequence of SEQ ID NO: 1; and

(d) a protein encoded by a DNA having a sequence that hybridizes to the DNA consisting of the nucleotide sequence of SEQ ID NO: 1, under conditions of hybridization in 6×SSC, 40% formamide at 25° C. and washing in 0.2×SSC at 55° C. wherein said DNA encodes a guanosine triphosphate-binding protein-coupled receptor which binds to one or more bile acid ligands selected from the group consisting of cholic acid, chenodeoxycholic acid, deoxycholic acid, and lithocholic acid, or the full complement of said DNA.

2. A kit for screening a ligand or an analog thereof, which binds to the protein according to claim 1 , comprising the protein according to claim 1 , and instructions for the screening.

Assignments (3)
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2011
From: BANYU PHARMACEUTICAL CO., LTD.
To: MSD K.K.
Reel/Frame 025920/0079 →